<?xml version="1.0" encoding="utf-8"?>
<html xmlns:MadCap="http://www.madcapsoftware.com/Schemas/MadCap.xsd" xml:lang="en-us" MadCap:lastBlockDepth="4" MadCap:lastHeight="2154" MadCap:lastWidth="450">
    <head><title></title>
        <link href="../Resources/Stylesheets/NGS 10_6.css" rel="stylesheet" />
    </head>
    <body>
        <h1 class="Heading1_1">Home Health Quickflips© #49</h1>
        <h2 class="Heading2_1">M2001-M2005: Medications</h2>
        <p>&#160;</p>
        <p><span class="span_20">These questions measure the </span><span class="span_20">use of “best practices” related to patient safety with medications and will be included in publically reported quality measures in the future.</span>
        </p>
        <p>&#160;</p>
        <p class="p_1"><span class="span_19">M2001 Drug Regimen Review</span><span class="span_19"> (DRR)</span><span class="span_20">:&#160; Identifies the presence of any potential</span><span class="span_20"> clinically </span><span class="span_20">significant problems with medications.</span>
        </p>
        <ul class="ul_5">
            <li class="li_38">Includes all medications – prescription, over the counter (including TPN and herbals), oral, topical, inhalant, pump, injection, intravenous and via enteral tube.</li>
            <li class="li_28"><span class="span_20">If the assessing clinician is a therapist, CMS allows collaboration between the assessing clinician (</span><span class="span_20">for example, </span><span class="span_20">PT) and an agency RN to complete the DRR and communicate with the physician and patient.</span><span class="span_20">&#160; </span><span class="span_20">C</span><span class="span_20">onsult your </span><span class="span_20">agency</span><span class="span_20">’s policies </span><span class="span_20">on each</span><span class="span_20"> discipli</span><span class="span_20">ne</span><span class="span_20">’</span><span class="span_20">s responsibility.</span>
            </li>
            <li class="li_38">“Problems” may include (but are not limited to):</li>
        </ul>
        <ul class="ul_6">
            <li class="li_7"><span class="span_17">Discrepancy between list of medication</span><span class="span_17"> from inpatient facility discharge </span><span class="span_17">instructions and medication patient has in the home</span>
            </li>
            <li class="ListParagraph_2">Inadequate symptom control</li>
            <li class="ListParagraph_2">Risk of medication errors by the patient</li>
            <li class="ListParagraph_2">Medications not obtained or issues that may interfere with obtaining or taking medications as prescribed</li>
            <li class="li_7"><span class="span_17">Signs/symptoms of adverse react</span><span class="span_17">ions</span>
            </li>
            <li class="ListParagraph_2">Potential interactions between otc/herbals and prescribed medications</li>
            <li class="li_32"><span class="span_17">Complex </span><span class="span_17">medications, i.e. multiple prescribers or multiple pharmacies, with high risk of interactions</span>
            </li>
        </ul>
        <p>&#160;</p>
        <p class="p_49">M2003 and M2005 are on the following page.</p>
        <p class="p_1">&#160;</p>
        <p>&#160;</p>
        <p><span class="span_19">M2003</span> <span class="span_19">Medication Follow-Up</span><span class="span_20">:&#160; Indicates whether the physician or physician-designee was contacted by midnight of the next calendar day to resolve </span><span class="span_20">clinically significant medication is</span><span class="span_20">sues, including reconciliation.</span></p>
        <p>&#160;</p>
        <p><span class="span_19">M2005</span> <span class="span_19">Medication Intervention</span><span class="span_20">:&#160; (Completed at DC from agency, Transfer or Death at Home.)&#160; Indicates whether physician was contacted by midnight of the nex</span><span class="span_20"> calendar</span><span class="span_20"> day </span><span class="span_20">to </span><span class="span_20">resolve </span><span class="span_20">clinically significant medication issues identified at SOC/ROC</span><span class="span_20"> OASIS assessment.</span></p>
        <p>&#160;</p>
        <p class="BodyText2_1">Hints for M2003 and M2005:</p>
        <ul class="ul_2">
            <li class="ListParagraph_3_1"><span class="span_36">To answer response code "1 - yes,” the physician (or physician-designee) must have been contacted by midnight the next calendar day following the identification of the problem, AND the physician must have acknowledged receipt of the </span><span class="span_36">information </span><span class="span_36">and/</span><span class="span_36">or provided </span><span class="span_36">further advice or </span><span class="span_36">instructions AND the intervention must have been completed.</span>
            </li>
            <li class="ListParagraph_3_1"><span class="span_36">Agency staff other than the clinician completing </span><span class="span_36">the </span><span class="span_36">OASIS may contact the physician.</span>
            </li>
            <li class="li_30">Communication may be by phone, fax, electronic communication, voice mail, etc.</li>
        </ul>
        <p>&#160;</p>
        <p>&#160;</p>
        <p>&#160;</p>
        <p>&#160;</p>
        <p>&#160;</p>
        <p>&#160;</p>
        <p>&#160;</p>
        <p>&#160;</p>
        <p>&#160;</p>
        <p>&#160;</p>
        <p>&#160;</p>
        <p>&#160;</p>
        <p>&#160;</p>
        <p>&#160;</p>
        <p>&#160;</p>
        <p><span class="span_28">For further information, see Chapter 3 of the OASIS-C2</span><span class="span_28"> Guidance Manual</span><span class="span_28">.</span>
        </p>
        <p>&#160;</p>
    </body>
</html>